Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To establish the bioequivalence of the new tipranavir oral solution formulation with the
current tipranavir oral solution formulation following single-dose administration. In each
case, 500 mg tipranavir was coadministered with 200 mg ritonavir.